SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-157221
Filing Date
2014-04-24
Accepted
2014-04-24 16:33:33
Documents
10
Effectiveness Date
2014-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d711793ddefa14a.htm DEFA14A 65957
2 GRAPHIC g711793img1.jpg GRAPHIC 2518
3 GRAPHIC g711793img2.jpg GRAPHIC 17382
4 GRAPHIC g711793img3.jpg GRAPHIC 3173
5 GRAPHIC g711793img4.jpg GRAPHIC 1802
6 GRAPHIC g711793img5.jpg GRAPHIC 6892
7 GRAPHIC g711793img6.jpg GRAPHIC 3126
8 GRAPHIC g711793img7.jpg GRAPHIC 3345
9 GRAPHIC g711793img8.jpg GRAPHIC 1118
10 GRAPHIC g711793img9.jpg GRAPHIC 6441
  Complete submission text file 0001193125-14-157221.txt   131253
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 14782088
SIC: 2834 Pharmaceutical Preparations